Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for refractory breathlessness
ACTRN12608000253303Phase 2Completed
- Sponsor
- Repatriation General Hospital
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Chronic breathlessness syndrome comparing Sertraline with Placebo (2 arms). Primary endpoint: Change in average morning and evening breathlessness. Started May 2008; status: completed.
02
Drugs
sertraline
03
Conditions
Chronic breathlessness syndrome
Beyond the preview
Go deeper on ACTRN12608000253303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000253303.